These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment. Dandel M, Lehmkuhl HB, Mulahasanovic S, Weng Y, Kemper D, Grauhan O, Knosalla C, Hetzer R. J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928 [Abstract] [Full Text] [Related]
10. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, Humbert M, Rainisio M, Rubin LJ, Simonneau G. Thorax; 2005 Dec; 60(12):1025-30. PubMed ID: 16055621 [Abstract] [Full Text] [Related]